Go offline with the Player FM app!
Biotech investor Bob Nelsen on AstraZeneca and his plan to revolutionize pharma
Manage episode 278399360 series 2826627
AstraZeneca and the University of Oxford today reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and which may be distributed earlier in developing countries. Dan digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who today launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.
Plus, Axios health care editor Sam Baker joins to discuss AstraZeneca’s interim analysis.
Learn more about your ad choices. Visit megaphone.fm/adchoices
750 episodes
Manage episode 278399360 series 2826627
AstraZeneca and the University of Oxford today reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and which may be distributed earlier in developing countries. Dan digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who today launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.
Plus, Axios health care editor Sam Baker joins to discuss AstraZeneca’s interim analysis.
Learn more about your ad choices. Visit megaphone.fm/adchoices
750 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.